A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)
Clinical trial NCT04490499 · COMPLETED
Trial details
- NCT number
- NCT04490499
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2020-12-29
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.